Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type
Clinical trial NCT03963193 · UNKNOWN
Trial details
- NCT number
- NCT03963193
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2020-06-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.